HomeCompareHHDS vs MRK

HHDS vs MRK: Dividend Comparison 2026

HHDS yields 1947.42% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HHDS wins by $7757039411.84M in total portfolio value
10 years
HHDS
HHDS
● Live price
1947.42%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7757039411.90M
Annual income
$7,045,364,447,504,868.00
Full HHDS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HHDS vs MRK

📍 HHDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHHDSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HHDS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HHDS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HHDS
Annual income on $10K today (after 15% tax)
$165,530.67/yr
After 10yr DRIP, annual income (after tax)
$5,988,559,780,379,138.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HHDS beats the other by $5,988,559,780,370,810.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HHDS + MRK for your $10,000?

HHDS: 50%MRK: 50%
100% MRK50/50100% HHDS
Portfolio after 10yr
$3878519705.98M
Annual income
$3,522,682,223,757,333.00/yr
Blended yield
90.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HHDS
No analyst data
Altman Z
-4.8
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HHDS buys
0
MRK buys
0
No recent congressional trades found for HHDS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHHDSMRK
Forward yield1947.42%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7757039411.90M$56.8K
Annual income after 10y$7,045,364,447,504,868.00$9,798.13
Total dividends collected$7706421709.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HHDS vs MRK ($10,000, DRIP)

YearHHDS PortfolioHHDS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$205,442$194,741.97$11,206$366.19+$194.2KHHDS
2$3,958,904$3,739,081.56$12,650$502.35+$3.95MHHDS
3$71,575,083$67,339,055.17$14,407$694.19+$71.56MHHDS
4$1,214,396,210$1,137,810,871.42$16,585$967.82+$1214.38MHHDS
5$19,341,410,844$18,042,006,899.05$19,342$1,363.89+$19341.39MHHDS
6$289,247,571,014$268,552,261,410.64$22,913$1,947.19+$289247.55MHHDS
7$4,062,910,085,069$3,753,415,184,084.88$27,662$2,823.89+$4062910.06MHHDS
8$53,620,462,900,612$49,273,149,109,587.61$34,159$4,173.35+$53620462.87MHHDS
9$665,116,789,152,691$607,742,893,849,036.50$43,337$6,308.80+$665116789.11MHHDS
10$7,757,039,411,898,247$7,045,364,447,504,868.00$56,776$9,798.13+$7757039411.84MHHDS

HHDS vs MRK: Complete Analysis 2026

HHDSStock

Our portfolio consists of office, industrial, retail and apartment assets, an unoccupied correctional facility and unimproved land. This portfolio largely represented the non-core assets of InvenTrust Properties Corp., our former parent, which spun off Highlands REIT in 2016. The spin-off allowed InvenTrust's management to focus on its core portfolio while providing Highlands with a dedicated management team to focus on maximizing the value of our portfolio.

Full HHDS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HHDS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HHDS vs SCHDHHDS vs JEPIHHDS vs OHHDS vs KOHHDS vs MAINHHDS vs JNJHHDS vs ABBVHHDS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.